a company for cancer & autoimmune treatment
Industry Biotechnology
A.I.dvisor indicates that over the last year, ZYME has been loosely correlated with ABSI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ZYME jumps, then ABSI could also see price increases.
Ticker / NAME | Correlation To ZYME | 1D Price Change % | ||
---|---|---|---|---|
ZYME | 100% | -1.79% | ||
ABSI - ZYME | 44% Loosely correlated | -9.32% | ||
RXRX - ZYME | 43% Loosely correlated | -16.62% | ||
XNCR - ZYME | 43% Loosely correlated | -3.14% | ||
BEAM - ZYME | 42% Loosely correlated | -8.55% | ||
VIR - ZYME | 42% Loosely correlated | -5.81% | ||
More |
Ticker / NAME | Correlation To ZYME | 1D Price Change % |
---|---|---|
ZYME | 100% | -1.79% |
cancer theme (87 stocks) | 50% Loosely correlated | +0.89% |
treatment theme (61 stocks) | 42% Loosely correlated | +0.91% |
pharmaceuticals theme (167 stocks) | 42% Loosely correlated | +0.82% |
autoimmune theme (3 stocks) | 38% Loosely correlated | -0.26% |
fighting cancer theme (12 stocks) | 36% Loosely correlated | +0.60% |
More |